Newswise — Lawrenceville, NJ, USA—April 12, 2022—ISPORThe Professional Society for Health Economics and Outcomes Research (HEOR) has announced its plenary sessions and speakers for ISPOR 2022, the Society’s annual international conference. ISPOR 2022 is scheduled for May 15-18 with the theme “The Future of HEOR in Patient-Centric Digital Health Systems”. ISPOR 2022 offers attendees both in-person and virtual conference experience options, with the in-person event being held in the Washington, DC, USA area. ISPOR 2022 marks the Society’s first in-person conference in 2 years.

Plenary sessions for ISPOR 2022 include:

Plenary 1: Ongoing health technology assessment
Monday, May 16, 2022
This plenary session will explore a series of case studies that showcase unique solutions to health technology assessment (HTA) challenges that health authorities have faced and that have been fueled during the pandemic. Since these factors have forced ETS to take place ‘on the go’, the session will provide essential information on how to accelerate the introduction of new products and assess their impact on patients’ lives. Speakers include:

  • Moderator: Ran D. Balicer, MD, PhD, MPH; Clalit Health Services; Tel Aviv, Israel
  • Noa Dagan, MD, PhD, MPH; Clalit Health Services; Tel Aviv, Israel
  • Douglas Kelly, MD; the United States Food and Drug Administration; Silver Spring, MD, USA
  • Joseph Ross, MD, MHS; Yale University; New Haven, Connecticut, USA


Plenary 2: Can Big Data analysis deliver on the promise of personalized medicine for all? Unpacking Health Equity Considerations
Tuesday, May 17, 2022
This plenary session will discuss how health decision makers can appropriately use health data for probabilistic risk assessment, which is often used for the successful application of big data analytics to personalized medicine. . The session will also illustrate the evolution and growing role of HEOR in addressing these issues. Speakers include:

  • Moderator: Ebere Onukwugha, MSc, PhD; University of Maryland School of Pharmacy; Baltimore, MD, USA
  • Bob Darin, MBA; Blue Health Intelligence; Chicago, Illinois, United States
  • Charles F. Manski, Ph.D.; Northwestern University; Evanston, IL, USA
  • Michael Pencina, PhD; Duke University School of Medicine; Durham, North Carolina, USA


Plenary 3: The patient (finally) at the center: how to leverage digital data to make patient-centric adoption, reimbursement and management decisions?
Wednesday, May 18, 2022
This plenary session will explore how digital health data can be used to target access to health technologies for the patients who would benefit most. Speakers will explore how digital data can provide HTA organizations direct use of real-world evidence. The session will also consider how this data can be used while maintaining appropriate patient engagement, privacy and data governance. Speakers include:

  • Moderator: Daniel Ollendorf, PhD; Tufts Medical Center; Boston, MA, USA
  • Moderator: Richard J. Willke, PhD; ISPOR; Lawrenceville, New Jersey, United States
  • Anurag Agrawal, PhD; CSIR Institute of Genomics and Integrative Biology; New Delhi, Massachusetts, India
  • Cat Davis Ahmed, MBA; The Family Heart Foundation; Pasadena, California, United States
  • Khaled El Emam, PhD; University of Ottawa; Ottawa, Canada
  • Yvette Venable; Institute of Clinical and Economic Examination; Waltham, MA, USA

ISPOR 2022 also presents an episode of its Signal series at ISPOR 2022. Signal the episodes feature topics and speakers that will shape healthcare decision-making over the decade, while addressing how HEOR can best contribute to solving healthcare’s biggest challenges.

Signal Episode: New analytical approaches to the challenges of the 21st century
Monday, May 16, 2022
This ISPOR Signal will discuss innovative approaches to understanding the complexity of people, man-made systems, economies and societies, while exploring how best to ensure their adaptability, recovery and resilience. Speakers include:

  • Moderator: Laura T. Pizzi, RPh, PharmD, MPH; ISPOR; Lawrenceville, New Jersey, United States
  • Harris Eyre, MD, Ph.D.; Organization for Economic Co-operation and Development (OECD)-PRODEO Institute Neuroscience-Inspired Policy Initiative; Los Angeles, California, United States
  • William Hynes, DPhil; Organization for Economic Co-operation and Development (OECD); Paris, France
  • Igor Linkov, MSc, PhD; U.S. Army Engineers Research and Development Center (ERDC) and Carnegie Mellon University; Pittsburgh, Pennsylvania, USA

ISPOR is recognized globally as the leading professional society for health economics and outcomes research and for its role in improving health care decisions. ISPOR 2022 attracts healthcare stakeholders interested in HEOR, including researchers and academics, evaluators and regulators, payers and policy makers, the life sciences industry, healthcare providers and health organizations. patient engagement.

Additional conference information can be found at: Conference Information | Program | Press | Exhibitions & Sponsorship

###

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) is an international, multi-stakeholder, nonprofit organization dedicated to advancing HEOR excellence to improve health decision-making around the world. The Society is the leading source for scientific, peer-reviewed and MEDLINE conferences®-indexed publications, best practice advice, education, collaboration, and tools/resources in the field.
Website | LinkedIn | Twitter (@ispororg) | YouTube | Facebook | instagram